Dr Matthias Fehr, CFA

More than ten years of experience in private and public equity investment management and research. Former senior sell-side analyst at Lombard Odier for the biotech and medical technology industries; researcher in asymmetric synthesis at the Swiss Federal Institute of Technology in collaboration with Roche. Honoured MSc and PhD in chemistry from the Swiss Federal Institute of Technology, (ETH) Zurich. Former board observer at PharmaSwiss SA (acquired by Valeant Pharmaceuticals).